Industry News
Shoppers will decide on GM: industry
Consumer perception of genetic modification (GM) has a big impact on research and the products produced by the agricultural biotechnology industry, delegates at a BioMelbourne BioBreakfast have heard. [ + ]
New Chinese bird flu strain: low risk to Aust
Chinese scientists have traced the deaths of around 1500 migratory waterbirds, including geese, gulls and cormorants on isolated Qinghai Lake in western China to a new strain of the lethal H5N1 influenza virus , or 'bird flu'. [ + ]
Australia-China science collaboration set to increase
Australia has cemented its strong relationship in science and technology with China following the signing of two new agreements aimed at enhancing collaboration between the two nations. [ + ]
Study offers new clues to killer viruses
Virologists have identified the cellular receptor that serves as a portal for infection by deadly bat-borne Henipa viruses, which have caused human deaths in Australia, Malaysia, Singapore and Bangladesh during the past decade. [ + ]
Meditech signs collaboration agreement with US firm Hyalose
Cancer therapy developer Meditech (ASX:MTR) has signed a research and development collaboration agreement with Hyalose, a privately-owned US biotech company. [ + ]
Biotechnology student resource revamped
Biotechnology Online, a national education resource aimed at making high-school students more aware of the ethics and scientific principles of biotechnology has been updated and relaunched. [ + ]
WEHI to share in US$21 million Gates grant for malaria research
Prof Alan Cowman and his team at The Walter and Eliza Hall Institute of Medical Research (WEHI) are part of an international consortium that has won a US$13 million Grand Challenge in Global Health grant to develop a treatment for malaria. [ + ]
Epitan raises AUD$3.5 million in private placement
Melbourne's Epitan (ASX:EPT) has raised AUD$3.5 million by way of a private placement, assisted by Mariner Corporate Finance, to institutional investors in Europe and Australia. [ + ]
Peptech awarded third patent for male dog contraceptive
Peptech Animal Health, a subsidiary of Peptech (ASX:PTD), has been granted an additional United States patent increasing the intellectual property protection of its peptide-based male dog contraceptive implant Suprelorin. [ + ]
In brief: GTG, Resonance Health, Sirtex
Genetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service. [ + ]
The Burrill view: Get ready for biotech's next phase
Steven Burrill's 'state of the industry' address is the star turn at the annual BIO conference in the US. Iain Scott was in the audience for this year's words of wisdom. [ + ]
New centre to look at approaches to imaging proteins
A new Centre of Excellence in Coherent X-Ray Science will be developed with an AUD$9 million ARC grant over five years, involving Australian and overseas universities and other organisations. [ + ]
Government medical research fund
The Commonwealth Government, through the National Health and Medical Research Council (NHMRC), has announced this year’s successful recipients of grants of a total more than A$100 million for leading medical research and clinical trials being conducted at universities and research centres.
[ + ]Big names on grant winners list
Some of the biggest names in Australian science are among the big winners of more than AUD$100 million in National Health and Medical Research Council grants, announced on Wednesday. [ + ]
Vet Biotech gets green light for horse stem cell therapy
Australian animal health company, Vet Biotechnology, has been given the green light to perform equine supply stem cell therapies for tendon and ligament injuries in Australia. [ + ]
